| # | Drug | Count |
|---|---|---|
| 0 | MONTELUKAST SODIUM | 564 |
| 1 | OMALIZUMAB | 108 |
| 2 | MONTELUKAST | 73 |
| 3 | FLUTICASONE PROPIONATE | 59 |
| 4 | ALBUTEROL SULFATE | 56 |
| 5 | FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE | 51 |
| 6 | PREDNISONE | 50 |
| 7 | BUDESONIDE | 44 |
| 8 | PREDNISOLONE | 39 |
| 9 | PREDNISOLONE ORAL | 39 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PELARGONIUM SIDOIDES | 1 | 0.1111 |
| 1 | AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE | 1 | 0.0156 |
| 2 | COSYNTROPIN | 2 | 0.0091 |
| 3 | TERBUTALINE SULFATE | 12 | 0.0065 |
| 4 | MONTELUKAST SODIUM | 564 | 0.0046 |
| 5 | ZAFIRLUKAST | 4 | 0.0044 |
| 6 | THEOPHYLLINE ANHYDROUS | 22 | 0.0018 |
| 7 | BECLOMETHASONE DIPROPIONATE | 10 | 0.0017 |
| 8 | AMINOPHYLLINE | 3 | 0.0015 |
| 9 | POLIDOCANOL | 2 | 0.0013 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 178 |
| 1 | Anti-IgE [EPC] | 108 |
| 2 | Leukotriene Receptor Antagonist [EPC] | 39 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 30 |
| 4 | Methylxanthine [EPC] | 22 |
| 5 | Proton Pump Inhibitor [EPC] | 21 |
| 6 | Platelet Aggregation Inhibitor [EPC] | 18 |
| 7 | Loop Diuretic [EPC] | 12 |
| 8 | Histamine-1 Receptor Antagonist [EPC] | 9 |
| 9 | HMG-CoA Reductase Inhibitor [EPC] | 8 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Sclerosing Agent [EPC] | 2 | 0.0044 |
| 1 | Adrenocorticotropic Hormone [EPC] | 2 | 0.0022 |
| 2 | Leukotriene Receptor Antagonist [EPC] | 39 | 0.0013 |
| 3 | Anti-IgE [EPC] | 108 | 0.0012 |
| 4 | Methylxanthine [EPC] | 22 | 0.0004 |
| 5 | Calcitonin [EPC] | 1 | 0.0003 |
| 6 | beta Lactamase Inhibitor [EPC] | 1 | 0.0002 |
| 7 | Paramagnetic Contrast Agent [EPC] | 1 | 0.0002 |
| 8 | Bile Acid [EPC] | 5 | 0.0002 |
| 9 | Provitamin D2 Compound [EPC] | 5 | 0.0002 |